Biologics Market Research Reports & Industry Analysis
The biologics industry includes a wide range of therapeutic products derived from biological sources and is a fundamental part of modern healthcare. Biologics play a vital role in advancing treatments for various diseases and conditions. MarketResearch.com offers a comprehensive collection of biologics industry reports to provide valuable insights into the most recent market trends, challenges, and opportunities to watch.
Biologics Market Growth Forecasts
- Access detailed information about a variety of distinct market segments, such as recombinant proteins, vaccines, and more.
- Obtain biologics market sizing and growth projections to gain a clear understanding of market potential and outlook.
- Analyze leading players and competitor strategies to stay one step ahead in a competitive market.
The MarketResearch.com Advantage
MakretResearch.com has been a trailblazer in the field of market research for more than two decades and continues to serve many of the largest life science and biotech companies in the world. With MarketResearch.com’s reliable data-driven insights, you can make informed decisions to guide your business towards success. Choose MarketResearch.com and gain the edge today.
Biologics Industry Research & Market Reports
-
Biopharmaceutical Courier - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 8.83% during the forecast period (2024-2029). The market is driven by the growing demand for personalized medicine, which drives the biopharma market's growth. The market is also ... Read More
-
Global Orthobiologics Market 2024-2028
... orthobiologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, ... Read More
-
Global Decentralised Clinical Trials Market Size Study, by Study Design (Interventional, Observational, Expanded Access), by Indication (Oncology, Cardiovascular, Immunology, Respiratory, Others), by Component (Mobile Healthcare, Telemedicine, Wearable Devices, Web-based Technology, Others), by End-users (Pharmaceutical and Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032
... Biopharmaceutical Companies, CROs, Others) and Regional Forecasts 2022-2032 Global Decentralised Clinical Trials Market is valued at approximately USD 9.30 billion in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Biologics Markets in China
... high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, ... Read More
-
Biologics Companies in China
... and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the ... Read More
-
Biologics Industry Forecasts - China Focus
... and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the ... Read More
-
Next Generation Sequencing Market - forecast to 2033 : By TYPE (RNA Sequencing, Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing, De Novo Sequencing), TECHNOLOGY (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Technologies), BY APPLICATION (Diagnostics, Oncology, Research Applications, Clinical Investigation, Reproductive Health, Drug Discovery, HLA Typing/Immune System Monitoring, Metagenomics and Epidemiology, Consumer Genomics, Agricultural & Animal Research), END-USER (Academic & Research Institutions, Biopharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations, Diagnostic Laboratories, Forensic Labs, Agricultural Research Centers, Government & Regulatory Agencies), PRODUCT (Sequencing, Data Analysis, Sample Preparation, Target Enrichment, Others), WORKFLOW (NGS Library Preparation Kits, Semi-automated Library Preparation, Automated Library Preparation, Sequencing, NGS
... Other Technologies), BY APPLICATION (Diagnostics, Oncology, Research Applications, Clinical Investigation, Reproductive Health, Drug Discovery, HLA Typing/Immune System Monitoring, Metagenomics and Epidemiology, Consumer Genomics, Agricultural & Animal Research), END-USER (Academic & Research Institutions, Biopharmaceutical & Biotechnology, ... Read More
-
Global Depth Filtration in Life Sciences (Biologics Manufacturing) Competitive Landscape Professional Research Report 2024
... process streams. It involves passing the process fluid through a porous matrix, typically made of materials like cellulose, diatomaceous earth, or synthetic polymers. As the fluid flows through the depth filter, impurities are trapped within ... Read More
-
Global Biosimilars and Innovative Biological Drugs Market Growth (Status and Outlook) 2024-2030
... factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical ... Read More
-
Viral Vector Manufacturing Market Report by Type (Adenoviral Vectors, Adeno-associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, and Others), Disease (Cancer, Genetic Disorders, Infectious Diseases, and Others), Application (Gene Therapy, Vaccinology), End User (Pharmaceutical and Biopharmaceutical Companies, Research Institutes), and Region 2024-2032
... Companies, Research Institutes), and Region 2024-2032 The global viral vector manufacturing market size reached US$ 1,200.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 7,681.6 Million by 2032, exhibiting a ... Read More
-
Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030
... America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of chronic diseases such as cancer, diabetes, and other autoimmune disorders, ... Read More
-
North America Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-Sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Country 2024-2032
... The North America pharmaceutical contract packaging market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% ... Read More
-
Cell Separation Technologies Market Report by Product (Instruments, Consumables), Cell Type (Human Cells, Animal Cells), Technology (Centrifugation-based Cell Separation, Surface marker-based Cell Separation, Filtration-based Cell Separation), Application (Oncology Research, Neuroscience Research, Stem Cell Research, Microbiology, Immunology Research, and Others), End User (Research Laboratories and Institute, Biotechnology and Biopharmaceutical Companies, Cell Banks), and Region 2024-2032
... Immunology Research, and Others), End User (Research Laboratories and Institute, Biotechnology and Biopharmaceutical Companies, Cell Banks), and Region 2024-2032 The global cell separation technologies market size reached US$ 10.4 Billion in 2023. Looking forward, IMARC ... Read More
-
Highly Potent Active Pharmaceutical Ingredients (HPAPIs) Market Report 2024-2034
... to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Rising Incidence ... Read More
-
Global Therapeutics Market (2024 Edition): Analysis By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area, By Region, By Country: Market Insights and Forecast (2020-2030)
... titled Global Therapeutics Market (2024 Edition) which provides a complete analysis of the Global Therapeutics industry in terms of market segmentation By Molecule Type (Biologics and Biosimilars, Small Molecules), By Therapeutic Area (Oncology, Infectious Disease, ... Read More
-
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2024
... used for the treatment of various diseases, including cancer, autoimmune disorders, and genetic diseases. Biologics are often highly complex and require specialized manufacturing techniques to ensure their safety, efficacy, and consistency. Biosimilars, on the other ... Read More
-
Global Rare Disease Treatment Competitive Landscape Professional Research Report 2024
... as orphan diseases, affect a relatively small number of people in the population. Due to their rarity, developing treatments for these conditions can pose significant challenges, including limited research, lack of available therapies, and difficulties ... Read More
-
Stem Cell Assays Market Assessment, By Assay Type [Viability/Cytotoxicity Assays, Isolation and Purification Assays, Cell Identification Assays, Proliferation Assays, Differentiation Assays, Function Assays, Apoptosis Assays], By Cell Type [Adult Stem Cells, Human Embryonic Stem Cells], By Product Type [Instruments, Reagents and Kits], By Application Type [Regenerative Medicine and Therapy Development, Drug Discovery and Development, Clinical Research], By End-user [Biopharmaceutical and Biotechnology Companies, Academic Institutes and Research Facilities, Others], By Region, Opportunities and Forecast, 2017-2031F
... By Product Type [Instruments, Reagents and Kits], By Application Type [Regenerative Medicine and Therapy Development, Drug Discovery and Development, Clinical Research], By End-user [Biopharmaceutical and Biotechnology Companies, Academic Institutes and Research Facilities, Others], By Region, ... Read More
-
Biologics Contract Development and Manufacturing Organization (CDMO) Market Forecasts to 2030 - Global Analysis By Product (Biosimilars, Biologics and Other Products), Service (Contract Manufacturing Organization (CMO) and Contract Research Organization (CRO)), Type, End User and By Geography
... By Geography According to Stratistics MRC, the Global Biologics Contract Development and Manufacturing Organization (CDMO) Market is accounted for $14.54 billion in 2024 and is expected to reach $33.45 billion by 2030 growing at a ... Read More
-
Biopharmaceuticals Market by Product Type (Monoclonal Antibodies, Purified Proteins, Recombinant Growth Factors), Services (Compendial & Multi Compendial Laboratory Testing, Custom Testing or Customer Proprietary Testing, Laboratory Testing), Raw Material Type, Application - Global Forecast 2024-2030
... The Biopharmaceuticals Market size was estimated at USD 574.04 billion in 2023 and expected to reach USD 627.19 billion in 2024, at a CAGR 9.74% to reach USD 1,100.51 billion by 2030. Biopharmaceuticals, also known ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 23.02 billion in 2023 and expected to reach USD 28.35 billion in 2024, at a CAGR 23.76% to reach USD 102.40 billion by 2030. Regenerative medicine is an interdisciplinary field that applies engineering and ... Read More
-
Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Global Forecast 2024-2030
... 5.05 billion in 2023 and expected to reach USD 5.80 billion in 2024, at a CAGR 14.51% to reach USD 13.04 billion by 2030. The recombinant proteins are created by inserting a modified gene into ... Read More
-
Clinical Trial Equipment & Ancillary Solutions Market by Product (Equipment, Services, Systems), Type (Biologic Drugs, Medical Devices, Small Molecules), Phase, End-Use, Indication - Global Forecast 2024-2030
... was estimated at USD 4.21 billion in 2023 and expected to reach USD 4.58 billion in 2024, at a CAGR 8.81% to reach USD 7.62 billion by 2030. Clinical trial equipment & ancillary solutions are ... Read More
-
Microplate Readers Market by Technology (Biologic Targeting, Microfluidics, Nanotechnology), Mode (Multimode, Single Mode), Application, End User - Global Forecast 2024-2030
... to reach USD 654.66 million in 2024, at a CAGR 8.25% to reach USD 1,059.13 million by 2030. Microplate readers are laboratory instruments used to detect chemical, biological, or physical matters of samples in microtiter ... Read More
-
Diabetic Foot Ulcer Treatment Market by Treatment (Antibiotic Medications, Biologics, Therapy Devices), Ulcer Type (Ischemic Ulcers, Neuro-Ischemic Ulcers, Neuropathic Ulcers), End-use - Global Forecast 2024-2030
... USD 5.35 billion in 2023 and expected to reach USD 5.69 billion in 2024, at a CAGR 6.56% to reach USD 8.35 billion by 2030. The diabetic foot ulcer (DFU) treatment includes a range of ... Read More
Research Assistance
